Patent details

Basic Information

Publication number:

EP3846807

PCT Application Number:

US2019049784

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP198581837

PCT Publication Number:

WO2020051356

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

IMIDAZOQUINOLINE COMPOUNDS AND USES THEREOF

French Title of Invention:

COMPOSÉS D'IMIDAZOQUINOLÉINE ET LEURS UTILISATIONS

German Title of Invention:

IMIDAZOCHINOLINVERBINDUNGEN UND VERWENDUNGEN DAVON

SPC Number:

Dates

Filing date:

05/09/2019

Grant date:

02/08/2023

EP Publication Date:

14/07/2021

PCT Publication Date:

12/03/2020

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

02/08/2023

EP B1 Publication Date:

02/08/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

05/09/2023

Expiration date:

05/09/2039

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

26/07/2023

 

 

Name:

Birdie Biopharmaceuticals, Inc.

Address:

4th Floor, Harbour Place 103 South Church Street P.O. Box 10240, Grand Cayman, KY1-1002, Cayman Islands (KY)

Inventor

Name:

YANG, Lihu

Address:

United States (US)

Priority

Priority Number:

201862728556 P

Priority Date:

07/09/2018

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/4375; A61K 31/4745; A61K 39/395; C07D 471/04;

Publication

European Patent Bulletin

1

Issue number:

202331

Publication date:

02/08/2023

Description:

Grant (B1)

2

Issue number:

202336

Publication date:

06/09/2023

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages